Rigel Pharmaceuticals, Inc. (RIGL)
32.04
+0.65
(+2.07%)
USD |
NASDAQ |
Apr 15, 16:00
32.04
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals Research and Development Expense (Annual) : 33.30M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Eli Lilly & Co. | 13.34B |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Amicus Therapeutics, Inc. | 135.84M |
| Nektar Therapeutics | 117.07M |
| Madrigal Pharmaceuticals, Inc. | 387.02M |